LY294002-NSC-697286-DataSheet-生命科学试剂-MedChemExpress_第1页
LY294002-NSC-697286-DataSheet-生命科学试剂-MedChemExpress_第2页
LY294002-NSC-697286-DataSheet-生命科学试剂-MedChemExpress_第3页
LY294002-NSC-697286-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemELY294002Cat. No.: HY-10108CAS No.: 154447-36-6Synonyms: NSC 697286; SF 1101分式: CHNO分量: 307.34作靶点: PI3K; Autophagy作通路: PI3K/Akt/mTOR; Autophagy储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO :

2、 14.9 mg/mL (48.48 mM; Need ultrasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 3.2537 mL 16.2686 mL 32.5373 mL5 mM 0.6507 mL 3.2537 mL 6.5075 mL10 mM 0.3254 mL 1.6269 mL 3.2537 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验

3、结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (8.13 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (8.13 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% c

4、orn oil1/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (8.13 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 LY294002种谱 PI3K 抑制剂,抑制 PI3K, PI3K 和 PI3K的 IC50 分别为 0.5, 0.57, 0.97 M 1。LY294002 也可抑制 CK2 的活性,IC50 为 98 nM 2。IC50 & Target p110 p110 p110 human CK20.5 M (IC50) 0.57 M (IC50) 0

5、.97 M (IC50) 98 nM (IC50)human CK22 Autophagy3.869 M (IC50)体外研究LY294002 (0-75 M; 24 hours and 48 hours) remarkably decreases CNE-2Z cells in a dose-dependentfashion 3.LY294002 (0-75 M; 24 hours and 48 hours ) induces CNE-2Z cells apoptosis rate in dose-dependent 3.LY294002 (10-75 M) significantly de

6、creases p-Akt (S473) expression levels and up-regulates caspase-9activity in CNE-2Z cells. Total Akt protein level is not difference with different concentration 3.Cell Proliferation Assay 3Cell Line: CNE-2Z cellsConcentration: 0 M, 10 M, 25 M, 50 M, and 75 MIncubation Time: 24 hours and 48 hoursRes

7、ult: Decreased CNE-2Z cells in a dose-dependent fashion.Apoptosis Analysis 3Cell Line: CNE-2Z cellsConcentration: 0 M, 10 M, 25 M, 50 M, and 75 MIncubation Time: 24 hours and 48 hoursResult: Induced apoptosis rate in dose-dependent.Western Blot Analysis 3Cell Line: CNE-2Z cellsConcentration: 10 M, 2

8、5 M, 50 M, and 75 MIncubation Time:Result: Decreased phosphorylated Akt (S473) expression levels were significantly, up-regulated2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEcaspase-9 activity in CNE-2Z cells in treated group.体内研究 Treatment with LY294002 (i.p.,50 mg/kg, 75 mg/kg) significantly r

9、educes mean NPC tumor burden ascompared with the control group. Treatment with 10 mg/kg or 25 mg/kg LY294002 is less effective indecreasing tumor burden. Mean NPC tumor burden treated with LY294002 is remarkably decreased in adose-dependent manner, whereas mean body weight is no obvious difference b

10、etween control and treatedgroups (LY294002, 10 mg/kg, 25 mg/kg, 50 mg/kg, and 75 mg/kg) 3.Animal Model: Athymic nude mice (6-8 weeks) with CNE-2Z xenograft 3Dosage: 10 mg/kg, 25 mg/kg, 50 mg/kg, and 75 mg/kgAdministration: Intraperitoneal injection; twice weekly, for 4 weeksResult: Mean Nasopharynge

11、al carcinoma (NPC) tumor burden was remarkably decreased in adose-dependent manner, whereas mean body weight was no obvious differencebetween control and treated groups.户使本产品发表的科研献 Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093. Blood. 2018 Jul 12;132(2):210-222. J Pineal Res. 2019 Apr;66(3):e12

12、552. Nat Commun. 2019 Jan 28;10(1):453. J Exp Med. 2016 Dec 12;213(13):2989-3005.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Chaussade C, et al. Evidence for functional redundancy of class IA PI3K isoforms. Biochem J. 2007 Jun 15;404(3):449-58.2. Gharbi SI, et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007 May 15;404(1):15-21.3. Jiang H, et al. Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma invitro and invivo. J Exp Clin Cancer Res. 2010 Apr 22;29:34.McePdfHe

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论